Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, T-Cell » Lymphoma, T-Cell, Cutaneous » Mycosis Fungoides
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, T-Cell » Lymphoma, T-Cell, Cutaneous » Mycosis Fungoides
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, T-Cell » Lymphoma, T-Cell, Cutaneous » Mycosis Fungoides
Description
A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected. MeSH
Hierarchy View
Subtype Terms (1)
Phase 2 Indicated Drugs (18)
Phase 1 Indicated Drugs (28)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (14)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (59)
American Society of Clinical Oncology
Cancer and Leukemia Group B (CALGB)
Cancer Immunotherapy Trials Network
Hoosier Cancer Research Network
James Graham Brown Cancer Center
Johannes Wesling Klinikum, Minden, Germany
Karl Landsteiner Private University of Health Sciences
Latin American Cooperative Onco-Haematology Group - Peru
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Rochester Skin Lymphoma Medical Group, PLLC
State University of New York, Buffalo
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.